As pet owners, we dread the day our companions show signs of illness, but a vet has explained everything you need to know.
IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...
Shares of leading pet healthcare diagnostics provider Idexx Laboratories (NASDAQ: IDXX) were up by 9% this week as of 4 p.m.
The department said it was hopeful it would take several more months, but "the time has come to put him to sleep." ...
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
Idexx Soars 10.5% After Crushing Q4 Estimates -- Big Buybacks and New Cancer Test Drive 2025 Outlook
Strong earnings, a $1.5B buyback, and game-changing diagnostics send Idexx stock soaring--investors take notice.
IDEXX outlined its 2025 revenue target of $4.055 billion to $4.170 billion, reflecting organic growth of 6% to 9%. The CAG Diagnostic recurring revenue is expected to grow between 5% and 8% ...
Reports Q4 revenue $954M, consensus $936.68M. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams ...
Idexx forecast revenue between $4.06 billion and $4.17 billion in 2025, in line with analysts' estimates of $4.14 billion. The company also guided for earnings per share in the range of $11.74 and $12 ...
5d
WIVB Buffalo on MSN‘Braver than brave’: Tucker Williams’ spirit lives on in Banditland battle against cancerSpending the night of his eighth birthday in the hospital, Tucker Williams was celebrated in Banditland. More than 10,000 ...
DENMARK - A Denmark family is in need of support after their 16-year-old son died from a car accident just months after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results